![logo](/logos/RPTX.webp)
Repare Therapeutics Inc.
NASDAQ:RPTX
2.82 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Repare Therapeutics Inc. |
Symbool | RPTX |
Munteenheid | USD |
Prijs | 2.82 |
Beurswaarde | 119,696,310 |
Dividendpercentage | 0% |
52-weken bereik | 2.71 - 13.85 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Lloyd Mitchell Segal |
Website | https://www.reparerx.com |
An error occurred while fetching data.
Over Repare Therapeutics Inc.
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)